Amgen Inc (LTS:0R0T)
$ 269.5 0 (0%) Market Cap: 160.64 Bil Enterprise Value: 212.02 Bil PE Ratio: 38.26 PB Ratio: 21.34 GF Score: 91/100

Amgen Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 07:50PM GMT
Release Date Price: $239.2 (+1.09%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

All right. Hello, everyone. Greetings from the virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst. And it's my pleasure to introduce our next company, Amgen; and Chairman and CEO and fellow Buckeye fan, Bob Bradway.

Please note that following this presentation, we will have a Q&A session right here in this same Zoom room where you are now, so you're able to also submit questions via the little blue Ask A Question button in your conference portal.

So with that, Bob, thanks very much for being here with us today. Let me turn things over to you.

Robert A. Bradway
Amgen Inc. - Chairman, CEO & President

Okay, Cory. Thanks for having us. We're delighted to be back again this year. We wish all of you a happy New Year. Let me just remind you before I jump in that we have slides, and I'll try to walk you through those. I think you have to control them on your end, but let's make our way

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot